Cy Scott, CEO, Headset

Where is the Industry? What Will Happen With Rescheduling? The Comment Period is Over.

The Future is Upon Us. Where is the Industry?
What Will Happen With Rescheduling?
The Comment Period is Over.

What is the Drug Enforcement Agency (DEA) going to do now?

In our May and June newsletters we noted that the DEA was accepting public comments on rescheduling cannabis from Schedule I to Schedule III. The public comment period is now over. The DEA has over 40,000 comments to sift through. What will the DEA do? What is a likely outcome? And will the impending election have any impact if the DEA does not have a decision or has not taken action prior to the election?

According to the latest HEADSET analysis, 94% of respondents favored rescheduling or descheduling cannabis.

Read the latest from HEADSET.

HEADSET’s Cy Scott delivered the Industry Update at CWCBExpo New York on June 5.  At that time, the comments were already overwhelmingly favorable for rescheduling or descheduling.  Listen to Cy’s entire presentation on this month’s archived video.

“If they take these comments seriously and really take into account what the people are saying, this is pretty overwhelming, right?

“You’re going to see new investors coming in, new opportunity, and more capital available, which is good, especially for an emerging market like New York.”

– Cy Scott, at CWCBExpo, June 5, 2024

HeadSet
Cy Scott, Co-founder. CEO, Headset
New York State Cannabis News

Licensing News from the Office of Cannabis Management (OCM), Cannabis Control Board (CCB) 

 

  • Issuing more licenses across several categories bringing the total for 2024 to 730
  • Amendments to packaging, labeling and marketing regulations for licensees
  • Ongoing efforts to padlock illicit shops across NYC and NYS
New York State Government

At the meeting, the CCB asserted that the cannabis industry in NYS is thriving and growing and that cannabis sales in 2024 will reach $200MM by this June. They said that to date, NYS cannabis sales have surpassed $420MM.

NYS OCM Office of Cannabis Management

Recent Adult-Use Dispensary Openings

Just A Little Higher Murray Hill
NEW YORK CITY | 628 2nd Avenue, New York 10016
Website: justalittlehigher.com

 

Stoops NYC
NEW YORK CITY | 182 Fifth Ave, New York 10010
Website: stoopsnyc.com

 

RISE Dispensary Halfmoon
HALFMOON | 1675 Route 9, Watkins Plaza, Halfmoon 12065
Website: risecannabis.com

 

Riverbend Dispensary
HUDSON | 531 Warren Street, Hudson 12534
Website: riverbenddispensary.com

 

Happy Times Cannabis Co.
CHEEKTOWAGA | 3807 Harlem Road, Cheektowaga 14215
Website: happytimescannabis.com

 

Silver Cannabis Company
SARATOGA SPRINGS | 75 Weibel Avenue, Saratoga Springs 12866
Website: silver-therapeutics.com/location/saratoga/

 

Twisted Cannabis FLX
GENEVA | 501 Exchange Street, Geneva 14456
Website:
twistedcannabisflx.com

 

Kings House of Fire
CORTLANDT MANOR | 3006 E Main Street, Cortlandt Manor 10567
Website: kingshouseoffire.com

 

Green Genius NYC
NEW YORK CITY | 214 3rd Avenue, New York 10003
Website: greengeniusnyc.com

 

Cussin’s Cannabis
SCHENECTADY | 2075 Central Avenue, Schenectady 12304
Website: cussinscanna.com

 

Polanco Brothers Ridgewood
NEW YORK CITY | 6633 Fresh Pond Road, Ridgewood 11385
Website: polancobrothersridgewood.com

 

Herb-Z
NEW YORK CITY | 109 E Taft Road, North Syracuse, 13212
Website: herb-z.com

 

Robinson’s Dispensary
ALBANY | 106 Everett Road, Albany, 12205

 

Arkansas, Nebraska and North Dakota Cannabis News

New Ballot Measures

Cannabis advocates in several states organized and gathered signatures to get legalization measures on their 2024 state ballots. The advocates in three states, Arkansas, Nebraska and North Dakota, had more than enough signatures to get the respective measures on the ballots. Arkansas and Nebraska seek medical ballot measures while the North Dakota ballot measure supports adult-use legalization.

NORML
Delaware Cannabis News

Transitioning Dispensaries from Medical to Adult Use

Delaware Governor John Carney signed a legislative bill that allows a pathway for medical licensees and dispensaries to transition to adult-use operators. That pathway has fees to transition. The bill is meant to catapult the development of the adult-use cannabis market.

South Africa Cannabis News

South Africa Works to Build its Cannabis and Hemp Sectors

In November of 2023, CWCBExpo editors visited the South African Consulate in New York City to discuss developing a cannabis industry. CWCBExpo has  been following that country’s cannabis progress since our visit. Here are the latest developments.

South Africa has embarked on several priorities for their country’s Investment Strategy that will spur job creation and growth, and foster recognition of people’s rights.

This past spring, South African President Ramaphosa took significant action regarding the Cannabis and Hemp sectors. In May, President Ramaphosa signed a law called the Cannabis for Private Purposes Act (CfPPA) which regulates the cultivation, possession and use of cannabis by adults in private settings. It also removed cannabis from their Drugs and Drug Trafficking Act. The President’s action opens up the medical market even further for the medicinal cannabis and for further regulatory opportunity for cannabis use among adults.

President Ramaphosa’s actions continued in June when he took the results of a Phakisa that explored the Cannabis and Hemp sectors. A “Phakisa” is a targeted program that seeks to fast-track the government’s targets and goals that help business, education, society and government. The Phakisa for cannabis and hemp brought stakeholders together from several groups. The goal was to develop a cohesive plan to define policy and get various sectors of the South African government to work together to build a meaningful regulatory program for the cannabis and hemp sectors.

President Cyril Ramaphosa
Art installation of South African record labels inside the South African Consulate in New York City, November 2023
Art installation of South African record labels inside the South African Consulate in New York City, November 2023.

THIS MONTH’S CWCBExpo NY 2024 ARCHIVED VIDEO

Industry Update by Cy Scott:
“Trends, Challenges and Opportunities –
Why New York is the Market to Watch in the Midst of Rescheduling”

This Industry Update, recorded at CWCBExpo on June 5, 2024, gives us a big-picture overview of the adult-use market across the United States including the implications of rescheduling from a Schedule I to a Schedule III classification. Also addressed are growth market trends, consumer behavior preferences and sales of different form factors. The data and analytics focuses on the New York Market and why you should put it front and center in your sights. This is a not to be missed market analysis.

Presented by Cy Scott, Co-Founder, CEO, Headset, with Tim Seymour, Portfolio Manager, CNBS Cannabis ETF; Co-Host, CNBC Fast Money.

Cy Scott and Tim Seymour, June 5 2024 at CWCBExpo NY

((from the left) Cy Scott and Tim Seymour

Don’t miss out. Get prime exhibit space now.

CWCBExpo, 11th Annual
June 4 – 5, 2025
Javits Convention Center, NYC

 

Spring Cannabis News from Across the Nation

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published. 

As spring blooms and 4/20 celebrations have come to a close, the national cannabis industry is on a high right now (pardon the pun). It’s already been a busy season in cannabis, including record-breaking sales and significant legislative developments. Join us as we recap recent headlines and explore what’s going on in the cannabis industry across the nation.

Congressional lawmakers continue demands for rescheduling

A bipartisan group of 21 congressional lawmakers is applying pressure to the Drug Enforcement Administration (DEA), urging swift action to reclassify cannabis from its restrictive Schedule 1 status. 

Led by Sens. Elizabeth Warren (D-MA) and John Fetterman (D-PA), along with Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA), the coalition penned a letter to DEA Administrator Anne Milgram and Attorney General Merrick Garland highlighting the urgent need for rescheduling. Noting the eight-month lapse since the U.S. Department of Health and Human Services (HHS) recommended this shift, lawmakers emphasized the imperative need for the DEA to act promptly. 

“Though marijuana is widely used and… associated with fewer adverse outcomes than alcohol, it remains in the most restrictive schedule,” the lawmakers wrote in the letter. “This placement produces a cascade of severe penalties for marijuana users and businesses, including for criminal records, immigration statuses, employment, taxation, health care, public housing, social services, and more.”

Cannabis tech firms report strong cannabis sales on 4/20 

Jane Technologies, a cannabis tech firm specializing in e-commerce and point-of-sail solutions, released a report highlighting strong cannabis sales during the 4/20 holiday. Jane’s network spans more than 2,500 dispensaries and brands across 39 U.S. states and Canada, offering a substantial perspective of activity within the industry on its flagship holiday.

The total number of transactions at Jane-powered locations reached 245,926 on 4/20, marking a notable 1.67% increase from the previous year’s figures. Total transactions for the entire holiday weekend surpassed 500,000, according to a statement released by the company. Jane Technologies also reported record-breaking sales figures in many states, most notably in Illinois, where sales at retailers in the Jane Technologies network soared to almost $4.5 million. 

“We saw record-breaking sales across the country this 4/20,” Soc Rosenfeld, Jane Technologies CEO and co-founder, said in a statement. “At Jane, it was an extremely successful day with well over half a million transactions completed on the platform this holiday weekend.”

According to the report, top-performing brands included Rythm, &Shine, STIIIZY, Savvy, and Float. Flower emerged as the most popular product type, followed closely by vapes and edibles. 

Cannabis POS platform Treez, which operates in 11 states and serves over 600 dispensaries, reported similarly booming sales data. According to data from Treez, there was a 120% increase in customers, products sold, and gross sales compared to 4/20 in 2023. 

However, according to Treez, the biggest spike in sales came the day prior as consumers sought to stock up ahead of the holiday. On April 19, Treez reported a 200% increase over last year’s numbers. That suggests that the day before 4/20 provides an even bigger bump for retailers, as many consumers prefer to refresh their stash ahead of the holiday festivities. 

Schumer pushes to pass cannabis banking bills in ‘bipartisan way’ 

Senate Majority Leader Chuck Schumer (D-NY) is once again championing a bipartisan effort to advance the Secure and Fair Enforcement Regulation (SAFER) Banking Act among a list of legislative priorities for the year. Speaking at a press briefing on April 23, Schumer emphasized the need for bipartisan cooperation in addressing various legislative matters. In addition to the SAFER Banking Act, he underscored the importance of addressing issues like insulin pricing, online child safety, and railway safety. 

“We’ve got a lot to do,” Schumer said. “And if we can work in a bipartisan way, we will.”

Schumer has repeatedly pushed to move the SAFER Banking Act, which previously cleared the Senate Banking Committee last September before dying without a floor vote. However, the Senate recently approved long-awaited and contentious appropriations legislation that may have cleared the way to focus on new legislative items like cannabis reform.

CWCBExpo is your gateway to the cannabis industry

The cannabis industry continues to rack up wins, from a record-breaking 4/20 to continued momentum on Capitol Hill. As the industry grows, CWCBExpo offers unparalleled opportunities to connect, learn, and stay updated on the latest news and trends shaping the cannabis industry. Register for our show and business exposition June 5 and 6 at the Javits Convention Center in New York City, and stay up to date on the latest changes and updates in the industry with our monthly news updates. 

Cannabis Gains Political Momentum as Legal Industry Grows  

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

March brought some dynamic shifts in the political culture surrounding cannabis. Vice President Kamala Harris led discussions on legalization and pardons, while Senate Democrats and House Republicans continued to push for cannabis banking reform. Could these developments be signs of growing momentum towards a shift in federal cannabis policy? Explore the impact of these updates on the cannabis industry nationwide.

VP Kamala Harris holds meeting on cannabis legalization and pardons 

Vice President Kamala Harris held a closed-door White House roundtable discussion on cannabis policy on March 15, 2024. Among the attendees were figures such as Cynthia Roseberry, Director of Policy and Government Affairs, Justice  at the ACLU; rapper Fat Joe; Chris Goldstein, Regional NORML organizer; Kentucky Governor Andy Beshear; and White House Director of Public Engagement Steven Benjamin. 

VP Harris used the discussion as an opportunity to emphasize the injustice of cannabis-related incarcerations, stating that “nobody should have to go to jail for smoking weed.” According to Goldstein, Harris also shared meaningful dialogue with Fat Joe regarding the importance of legalization and expressed support for ending the federal prohibition.

“The moment where she raised her hands in the air and said, “We need to legalize marijuana” — saying those words out loud, saying it in the Roosevelt Room, it did feel very meaningful, and it wasn’t lost on anyone there what was going on in that moment,” Goldstein told Marijuana Moment.

The Department of Health and Human Services (HHS) conducted a scheduling review in August 2023 and concluded to the DEA that cannabis be reclassified to a Schedule III drug. While there is no timeline for when the DEA’s review could take place, conversations like these represent strides forward. “This is the first time the White House has asked for a scheduling review in the right manner, so we don’t have a context for how long they might be able to run out the clock,” Goldstein added. 

Senate Democrats and House Republicans continue to push for cannabis banking bill 

As Congress nears the passage of a package of spending bills for the 2024 Fiscal Year, bipartisan attention has again turned to advancing the Secure and Fair Enforcement Regulation (SAFER) Banking Act. Senate Banking Committee Chairman Sherrod Brown (D-OH) expressed optimism about the bill’s prospects in a recent interview, sharing hope that the measure will immediately pass on the floor this year. 

“We’ve got a House that’s still not moving on stuff that matters to Republicans,” he said, referencing party divisions in the chamber. “The truth is that’s really pushed us back on what we can do in the Senate with floor time.”

In parallel, House Majority Whip Tom Emmer (R-MN) reiterated his support of the SAFER Banking Act during an American Bankers Association (ABA) summit. Emmer emphasized the need for federal action on banking reform, citing the sluggish pace of incremental reform despite his personal stance on the issue.

“For whatever reason, the federal government has been slow to get that done,” he stated. “Like it or not, if your state has enacted laws creating this as a legal entity that is legitimate, our bankers should be allowed to bank,” he added. “It’s not whether you are a marijuana lover or hater, it’s more: This is a legitimate business that has been approved by the representative government of that state.”

IRS clarifies cannabis cash reporting regulations 

The Internal Revenue Service (IRS) issued a memo clarifying the rules for reporting large cash payments between cannabis businesses. In response to a request for guidance on Form 8300, which mandates reporting for cash payments exceeding $10,000, the IRS emphasized that such transactions should not automatically be flagged as “suspicious” solely due to the federal prohibition of cannabis. 

An example of the other language in the memo includes:

Question 3: “Is it reasonable for a legalized substance business to check the suspicious activity box simply because of the type of product they deal with?”

Answer 3: No. When marking the suspicious activity box is purely done defensively, much like a Money Service Business filing defensive Significant Activity Reports, this is an abuse of the use of that box. If they are solely marking the box because of the industry and for no other reason, this is not an appropriate use of the box. If a business is checking the box in these circumstances, the agent should inform them that continuing to check the box could result in penalties for inaccurate forms. Of course, this depends on the facts and circumstances in each case.”

“We are working on additional guidance on questions related to cash couriers/armored cars who transport cash between growers/manufacturers and dispensaries/sellers,” reads the memo. 

Keeping tabs on the cannabis industry’s progress nationwide

Gradually, the federal government has made progress toward cannabis reform, and there is as much reason to be optimistic as ever. Given recent developments, it’s important to continue our path toward comprehensive reform, promising a future of equity, accessibility, and opportunity within the legal cannabis industry. Looking ahead, stay tuned for updates on these matters and mark your calendars for this year’s CWCBExpo on June 5 and 6 at the Javits Convention Center in New York City, where professionals gather to network, learn, and shape the future together. 

Crowds at Entrance, CWCBExpo NY 2023

Law Enforcement Groups Push for Rescheduling & More

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

 

February held some big headlines for the cannabis industry, including groundbreaking research into cannabinoids and terpenes, Vice President Kamala Harris meeting with pardon recipients, and law enforcement leaders advocating for cannabis rescheduling. Join us as we dive into the latest cannabis news nationwide and how it’s impacting the industry and consumers everywhere.

 

Law enforcement group pushes for cannabis rescheduling

 

A coalition of police chiefs and prosecutors, represented by the Law Enforcement Leaders to Reduce Crime & Incarceration (LEL), has called upon the Biden administration to reclassify cannabis under federal law. Led by prominent figures such as U.S. Drug Enforcement Administrator (DEA) Anne Milgram, the organization advocates for rescheduling cannabis to Schedule III. 

 

In a letter addressed to the administration, the coalition underscored the benefits of rescheduling, including the prioritization of limited public safety resources. “We believe that reclassification under schedule III would be an important step to help both federal and state law enforcement better prioritize limited public safety resources,” the LEL wrote in the letter. “Moreover, rescheduling would also allow legal markets to compete on a level playing field, potentially leading to greater reinvestments in critical programs that can bolster public safety.” 

  

The call from LEL comes as the DEA is mulling a proposal from the U.S. Department of Health and Human Services to reschedule cannabis as a Schedule III controlled substance. Rescheduling cannabis to Schedule III would represent a landmark step towards comprehensive federal cannabis reform. 

 

The letter from LEL is the latest in mounting pressure for regulators to consider cannabis reform. Last month, Congressional Democrats sent a letter to the DEA requesting cannabis be descheduled entirely, eliminating its status as a controlled substance altogether.

 

New study assesses cannabis compounds and the entourage effects

 

A recent study published in the journal Molecules delved into the intricate interactions between cannabinoids, terpenes, and other chemical compounds found in cannabis, shedding light on the so-called “entourage effect”, which describes the collaborative dynamics of these components and their combined effects. 

 

The study, published in January 2024, confirmed the concept of the entourage effect, which has often been controversial among researchers. The study emphasized that it’s not merely THC and CBD, but the complex interplay of molecules, that shape our individual cannabis experience. 

 

“In cannabis science, cannabinoids, terpenes, and flavonoids have often been overlooked, with much of the literature focusing predominantly on the major cannabinoids THC and CBD,” reports the team behind the new study. “However, emerging evidence suggests that these constituents, particularly cannabinoids and terpenes, play a substantial role in interacting and collaborating. This interplay gives rise to the diverse effects, benefits, and side effects observed among different cannabis strains, which can vary in the ratios of these components.”

 

The research represents a step forward in our understanding of cannabis and how it works. While much research is still needed, advancing our understanding of the entourage effect brings us a step closer to maximizing the therapeutic potential of the plant.

 

Kamala Harris reaches out to cannabis pardon recipients 

 

Vice President Kamala Harris’s office has been actively engaging with those who have received pardons for cannabis possession under President Biden’s clemency proclamations, aiming to ensure a smooth process and broader discussion into cannabis policy reform. 

 

Chris Goldstein, a prominent activist recently pardoned for a 2014 possession case, revealed that the vice president’s office contacted him and subsequently met with three staffers to discuss his certification experience, as well as cannabis reform proposals such as descheduling and expungement. 

 

Goldstein commended the office for their attentiveness and keen interest in understanding the nuances of cannabis policy reform. He raised the point that the pardons people received over possession did not clear their records, which still need to be expunged. He also noted that the office “absolutely heard that” and understood the “nuance” of the policy issue.

 

“I want to give them credit for this, because they were reaching out to pretty much anybody who they could who had gotten a pardon recently through the Department of Justice and trying to communicate with people about the pardons and make sure the process was going well,” he told Marijuana Moment. “It seemed like they were really invested in making sure that people had an easy process in getting the pardons and that it was easy to apply, it was a short waiting period, all those things.”

 

Poll find 17% of American adults consume cannabis 

 

According to a new Gallup poll, approximately 17% of American adults reported consuming cannabis, remaining relatively stable compared to the previous year’s 16% but significantly increased from just 11% in 2015.

 

“Age is a significant driver of the likelihood of smoking marijuana. About a quarter of young adults, those aged 18 to 34, say they smoke marijuana (26%), but reported use falls to 18% among adults aged 35 to 54 and is even lower, 11%, among adults aged 55 and older,” reads the Gallup analysis. 

 

Other standouts from the responses included:

  • Men (19%) are more likely than women (14%) to consume cannabis.
  • College graduates (9%) are about half as likely as those without a college degree (21%) to consume cannabis.
  • Democrats (22%) are more likely than Republicans (12%) to report consuming cannabis, with independents’ (17%) falling between them.

Exploring the future of cannabis with CWCBExpo 

 

As we wrap up February, one thing is clear: the future of cannabis is dynamic and full of promise. Looking ahead, we remain committed to collaboration, innovation, and advocacy as we shape a bright future for the cannabis industry. Stay up to date with our monthly news updates, or join us in person at CWCBExpo this June to network with industry leaders and learn from cannabis experts. 

Loading...
Skip to content
Loading...
Skip to content